218 related articles for article (PubMed ID: 35674965)
1. An Immunocompromised Mouse Model of Candida auris Systemic Infection.
Herrada J; Roberts K; Gamal A; Long L; Ghannoum MA
Methods Mol Biol; 2022; 2517():317-328. PubMed ID: 35674965
[TBL] [Abstract][Full Text] [Related]
2. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.
Flores-Maldonado O; González GM; Andrade A; Montoya A; Treviño-Rangel R; Silva-Sánchez A; Becerril-García MA
Microb Pathog; 2021 Dec; 161(Pt B):105285. PubMed ID: 34774701
[TBL] [Abstract][Full Text] [Related]
4. Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review.
de Moraes DC
J Mycol Med; 2022 Mar; 32(1):101232. PubMed ID: 34883404
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Skin Colonization and Decolonization Models for Candida auris.
Herrada J; Gamal A; Long L; Ghannoum MA
Methods Mol Biol; 2022; 2517():269-285. PubMed ID: 35674962
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
[TBL] [Abstract][Full Text] [Related]
7. Review of treatment options for a multidrug-resistant fungus: Candida auris.
Wang S; Pan J; Gu L; Wang W; Wei B; Zhang H; Chen J; Wang H
Med Mycol; 2024 Jan; 62(1):. PubMed ID: 38066698
[TBL] [Abstract][Full Text] [Related]
8. The first invasive
Tsai YT; Lu PL; Tang HJ; Huang CH; Hung WC; Tseng YT; Lee KM; Lin SY
Emerg Microbes Infect; 2022 Dec; 11(1):1867-1875. PubMed ID: 35811508
[No Abstract] [Full Text] [Related]
9. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a new chemical scaffold for the treatment of superbug
Tu J; Zhu T; Wang Q; Yang W; Huang Y; Xu D; Liu N; Sheng C
Emerg Microbes Infect; 2023 Dec; 12(1):2208687. PubMed ID: 37102336
[No Abstract] [Full Text] [Related]
11. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
[No Abstract] [Full Text] [Related]
12. Experimental Mouse Models of Disseminated Candida auris Infection.
Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated candidiasis and the emerging concern of Candida auris infections.
Tsai CS; Lee SS; Chen WC; Tseng CH; Lee NY; Chen PL; Li MC; Syue LS; Lo CL; Ko WC; Hung YP
J Microbiol Immunol Infect; 2023 Aug; 56(4):672-679. PubMed ID: 36543722
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
Gamal A; Long L; Herrada J; Aram J; McCormick TS; Ghannoum MA
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0054921. PubMed ID: 34228541
[TBL] [Abstract][Full Text] [Related]
15. CDC: Candida auris Fungal Infections and Drug Resistance on the Rise.
Harris E
JAMA; 2023 Apr; 329(15):1248. PubMed ID: 36988997
[No Abstract] [Full Text] [Related]
16. Enhanced antifungal activity of posaconazole against Candida auris by HIV protease inhibitors, atazanavir and saquinavir.
Elgammal Y; Salama EA; Seleem MN
Sci Rep; 2024 Jan; 14(1):1571. PubMed ID: 38238403
[TBL] [Abstract][Full Text] [Related]
17.
Du H; Bing J; Nobile CJ; Huang G
Virulence; 2022 Dec; 13(1):589-591. PubMed ID: 35441578
[No Abstract] [Full Text] [Related]
18. Impact of
Sharma D; Paul RA; Rudramurthy SM; Kashyap N; Bhattacharya S; Soman R; Shankarnarayan SA; Chavan D; Singh S; Das P; Kaur H; Ghosh AK; Prasad R; Sanyal K; Chakrabarti A
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0165221. PubMed ID: 34780273
[TBL] [Abstract][Full Text] [Related]
19. The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates
Wiederhold NP; Lockhart SR; Najvar LK; Berkow EL; Jaramillo R; Olivo M; Garvey EP; Yates CM; Schotzinger RJ; Catano G; Patterson TF
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530603
[No Abstract] [Full Text] [Related]
20. Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.
Wurster S; Albert ND; Kontoyiannis DP
Methods Mol Biol; 2022; 2517():299-316. PubMed ID: 35674964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
